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Abstract 
The Hordaland Women’s Cohort 
A longitudinal study on urinary incontinence in middle-aged women 
David Jahanlu (PhD-dissertation) 
 
Urinary incontinence (UI) is a prevalent problem among middle-aged women, and 
many epidemiological studies have investigated this problem. Most of these studies 
are cross-sectional and only few longitudinal studies have been conducted. Thus, the 
knowledge about incidence, remission and natural history of UI is scarce. The aim of 
that present dissertation was to answer major epidemiological questions about 
incidence, progress and remission of UI in middle-aged women.  
The Hordaland Women’s Cohort was established in 1997 and designed as a 
prospective longitudinal study for 15 years. The source population was from 
Hordaland Health Study (HUSK), which was a joint epidemiological research project 
and a part of national health project called Cohort of Norway (CONOR). HUSK 
invited all individuals in Hordaland County born between 1953-57, and among 14300 
women in Hordaland, almost 9900 (70%) participated in HUSK. We took a one-fifth 
random sample of female HUSK participants and 2230 women consented to take part 
in the Women’s Cohort. In 2007 the Cohort reached a ten-year follow up with six 
checkpoints and the present dissertation is based on the analyses of data for this 
period of the Cohort.  
In the first sub-study (Paper I), the data from source (HUSK) population was used to 
compare the basic demographic data and urologic characteristics between the women 
who participated in the Cohort and rest of the women in HUSK. For demographic 
data, 2230 women in the Cohort were compared with 7746 women in HUSK, who 
were not selected for the Cohort. For urologic characteristics, we used a HUSK sub-
questionnaire with 5320 participants. Of these, 1920 were in the Cohort and we 
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compared their urological characteristics with those of the rest of the women 
(n=3400). The results demographic data showed a very high similarity for 
demographic data. The only significant differences were observed for higher 
education (p=0.001) and higher annual family income (p=0.018) among the women 
in the Cohort.  
Analyzing data for urinary conditions showed few statistical differences between 
women in the Cohort and the rest of the women; they had somewhat more UI 
(p=0.040), more stress UI (p=0.048) and less amount of leakage (p=0.015) in the 
Cohort participants. Prevalence rate of any UI was 28.9% in the Cohort and 24.8% in 
the rest of women in HUSK. This paper also described the research methodology in 
details with intention of using it as reference for any further data analysis from the 
Cohort.  
The second sub-study (Paper II) explored the prevalence, incidence and remission of 
UI. In this paper the possibility of an early prevalence peak in middle-aged women 
was investigated. We first used all data from the Cohort, which was gathered during 
ten years in six waves, to analyze the prevalence curve of UI. Furthermore, for more 
detailed analyses of prevalence, incidence and remission, data from the women who 
answered all six questionnaires were used. We sorted data in terms of age with eight 
groups in the age span of 41-55 years. Definition of UI was based on the results from 
the Incontinence Severity Index (ISI) and women with an ISI of more than 0 were 
defined as having incontinence. Women with an ISI equal to 3 or more, who reported 
their UI to be bothersome, were defined as having significant UI. According to our 
data, the prevalence of any UI in women aged 41-42 year was about 37% and 
increased gradually up to 50% in the age of 51-52 years, after which it started to 
decrease gradually. The changing patterns for incidence and remission were the same 
until age 51-52, but then the incidence started to decrease while the remission was 
increasing, which could have caused the peak in the prevalence of UI. Stress UI was 
the major type and most cases of UI were of low severity. Over the observation 
period, while the proportion of mixed UI increased by age, the proportion of stress UI 
remained relatively stable and the proportion of urgency UI slightly varied between 
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aged groups. Regarding type shift, proportion of moderate UI remained relatively 
stable, while slight UI decreased and severe/very severe UI increased by age.  
The main aim of the third sub-study (Paper III) was to investigate the natural history 
of UI with focus on finding the new-onset UI and its changes in types and severity. 
First we defined continent women in the baseline by using the same definition of UI 
as in Paper II. We followed them wave by wave during 10 years and 5 checkpoints. 
Almost half of them reported to have UI, at least once during 10 years. The types of 
new-onset UI by type were distributed as: 49.8% stress, 18.3% urgency and 20.3% 
mixed UI. By severity, 89.3% of women started with slight UI, none of them reported 
severe UI in the first report. In follow up of women for 2 waves after the new-onset 
UI, one-third of them had persistent UI, the type and severity was mainly stress UI 
with slight severity, with a low tendency for shifting the type or severity. We also 
suggest out that mixed UI is not necessarily the final stage of UI.  
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Sammendrag (Abstract in Norwegian) 
Kvinnekohorten i Hordaland 
David Jahanlu (ph.d.-avhandling) 
 
Urininkontinens (UI) er et utbredt problem blant middelaldrende kvinner og mange 
epidemiologiske studier har undersøkt dette symptomet. De fleste av disse studiene er 
basert på tverrsnittsdata og det er bare gjort noen få longitudinelle studier på området. 
Som følge av dette har vi begrenset kunnskap om forekomsten, remisjon og forløpet 
av UI. Målet med avhandlingen var å finne svar på viktige epidemiologiske spørsmål 
som start, utvikling og remisjon av UI hos middelaldrende kvinner. 
Kvinnekohorten i Hordaland ble opprettet i 1997 og hadde til hensikt å være en 
prospektiv longitudinell studie over 15 år. Kildepopulasjonen var fra 
Hordalandsundersøkelsen (HUSK), som var et felles epidemiologisk 
forskningsprosjekt og en del av det nasjonale helseprosjektet Cohort of Norway 
(CONOR). HUSK omfattet alle personer i Hordaland fylke født mellom 1953 og 
1957, og blant 14300 kvinner i Hordaland deltok nesten 9900 (70%) i HUSK. Vi 
gjorde et tilfeldig utvalg av en femdel av kvinnene som deltok i HUSK, og 2230 
kvinner gav sitt samtykke til å delta i Kohorten. I 2007 hadde man gjennomført  
oppfølging med seks kontrollpunkt og denne avhandlingen er basert på analysen av 
dataene for denne perioden av studien. 
I den første delstudien (Artikkel 1) brukte vi data fra kildepopulasjonen (HUSK) for 
å sammenligne de demografiske data og urologiske forhold mellom kvinnene som 
deltok i Kohorten og resten av kvinnene i HUSK. 2230 kvinner i Kohorten ble 
sammenlignet med 7746 kvinner i HUSK. For urologiske forhold brukte vi et 
delspørreskjema fra HUSK svart av 5320 deltakere. 1920 av disse var i Kohorten og 
vi sammenlignet deres urologiske særtrekk med resten av kvinnene (n=3400). 
Demografiske data viste stor grad av likhet mellom gruppene av kvinner. De eneste 
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forskjellene vi fant av betydning var for høyere utdanning (p=0,001) og større årlig 
familieinntekt (p=0,010) blant kvinnene i Kohorten. Dataene for urologiske variabler 
viste få statistiske forskjeller mellom kvinnene i Kohorten og resten av kvinnene; 
men noe mer UI  (p=0,040), mer stress UI (p=0,048) og mindre lekkasje (p=0,015) 
hos deltakerne i Kohorten. Prevalensen av UI var 28,9 % i Kohorten og 24,8 % hos 
resten av kvinnene i HUSK.  
Analysen viste at deltakerne i Kohorten er like kildebefolkningen og således 
representativ for deltakerne i HUSK. Den viste også at for UI var resultatene forenlig 
med funn fra tidligere forskning i Norge. I artikkelen er forskningsmetoden også 
beskrevet i detalj og hensikten med dette er å kunne bruke artikkelen som en 
referanse for den videre bruken av data i Kvinnekohorten.  
Den andre del (Artikkel 2) undersøkte prevalens, insidens og remisjon av UI. Vi ville 
også se om vi fant et mulig tidlig toppunkt for prevalensen hos middelaldrende 
kvinner. Vi brukte først hele materialet fra Kohorten samlet inn gjennom en 10- års 
periode i 6 bølger til å analysere forekomsten av UI. Deretter, for mer detaljerte 
analyser av prevalens og remisjon brukte vi bare data fra kvinner som hadde svart på 
alle de 6 spørreskjemaene. Vi sorterte dataene utifra alder (41-55) og fordelte vi 
kvinnene i 8 aldersgrupper. 
Definisjon av UI var basert på resultatene fra Incontinence Severity Index (ISI), og 
kvinner som hadde mer enn 0 i skåre i følge ISI ble definert som inkontinente. 
Kvinner med 3 og mer på ISI og som beskrev sin UI som plagsom ble definert som å 
ha alvorlig UI. Ifølge våre data var forekomsten av en eller annen form for UI hos 
kvinner i alderen 41-42 år rundt 37% og den økte gradvis opp til 50% i alderen 51- 52 
år. Etter denne alderen begynte prevalensen gradvis å synke. Insidens og remisjon 
fulgte samme mønster til kvinnene var 51- 52 år, men da begynte insidensen å synke 
mens remisjon økte. Dette er forklaringen på at man hadde et toppunkt i utbredelsen 
av UI. Hovedtypen var stress UI og de fleste hadde UI lav alvorlighetsgrad. I 
observasjonsperioden fant vi en forandring i fordelingen av både type og 
alvorlighetsgrad. 
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Hovedformålet med den tredje del  (Artikkel 3) var å undersøke det naturlige 
forløpet for UI ved ulike typer av UI og ulike alvorlighetsgrader. Vi fokuserte på 
nyoppstått UI og dens utvikling de neste 4 årene. Ved å bruke den samme 
definisjonen av UI som i Artikkel 2, inkluderte vi kontinente kvinner i den første 
bølgen og fulgte dem gjennom de neste 5 bølgene. Nesten halvparten av kontinente 
kvinner i basislinjen rapporterte et frembrudd av UI i løpet av 10 år. Fordelingen av 
type var 49,8%, 18,3% og 20,3% for henholdsvis stress-, urgency- og blandet 
urininkontinens. Majoriteten av kvinnene (89,3%) fikk lett UI i begynnelsen og ingen 
rapporterte alvorlig UI allerede fra debut av UI. Studien viser at det blant 
middelaldrende kvinner med nylig frembrudd av UI er det stress- typen som er mest 
vanlig og at den er av lav alvorlighetsgrad. En tredel av kvinnene utviklet varig 
inkontinens med liten tendens til forandring av både type og alvorlighetsgrad 
gjennom årenes løp. Blandet UI er trolig ikke et siste stadium av UI i denne 
aldersgruppen. 
 18 
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1. Introduction 
Urinary incontinence (UI) affects women of all ages, and is at least twice as 
prevalent, compared with men1. This common problem, mostly regarded as a 
symptom, shows a wide range of severity and different types2. Incontinence is not a 
life-threatening disease, but the symptoms may seriously influence the physical, 
psychological, and social wellbeing of the affected individuals.  
In order to understand and manage UI, it is necessary to study the epidemiology and 
natural course of UI. This matter, especially in middle-aged women, is not very well 
described and rather little is known about onset and progress of UI in this period. 
Advancing the basic knowledge of epidemiology is also necessary for finding the 
risks and protective factors, which may lead to primary or secondary disease 
prevention. By finding epidemiological parameters (incidence, prevalence, 
remission), understanding the natural history of UI will be possible. Many studies are 
dedicated to find out the prevalence of UI, mostly cross-sectional epidemiological 
studies, that have shown an increase in prevalence of UI with aging and particularly 
by the time a woman enters the perimenopausal years3-5, and several authors have 
reported a prevalence peak in midlife6-9. However, prospective studies with detailed 
analyses of the incidence and remission of UI are scarce. 
The present work is the first set of data analyses from the Hordaland Women’s 
Cohort. This Cohort is a prospective longitudinal study with emphasis on prevalence, 
incidence, remission and natural history of UI during perimenopausal stages. To 
begin with, I refer to the previous and current consensus definitions of UI. I then go 
on to discuss the epidemiological terms and literatures regarding UI in middle-aged 
women.  
The introductory part of this thesis is based on a review of the literature up to spring 
2014. An extended literature search in PubMed and other relevant sources was 
performed, using a relevant series of key words. Major reviews and book chapters 
were also searched for relevant papers. The research group for UI, which I am part of, 
have for many years performed systematical literature searches every month. We use 
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a very broad search algorithm in order to retrieve all relevant papers: “urinary 
incontinence” [MeSH Terms] OR "incontinence pads"[MeSH Terms].  
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2. Definition of Urinary Incontinence 
One of the challenges in all studies of diseases is to find out and agree upon a 
uniform definition of disease. The lack of a uniform definition of UI caused many 
discrepancies in assessing and particularly in comparing the findings from different 
epidemiological studies10. 
UI may be diagnosed subjectively (self-reported) or objectively (clinically). The 
clinical aspects of UI should be approached differently compared to self-reported UI. 
Clinically, the diagnosis of UI should be based on sign and symptoms or specific 
diagnostic tests. A subjectively diagnosed UI is more suitable for epidemiological 
studies11. One of the disadvantages of self-reported UI is however a possible 
misclassification of UI12. This work is based on a subjective and self-reported 
definition of UI. 
The pioneer of standardization of definitions of UI is the International Continence 
Society (ICS). ICS is an international multidisciplinary society and one major part of 
their aims is the study of lower urinary tract symptoms (LUTS). ICS is a co-organizer 
of several conferences called International Consultation on Incontinence (ICI). The 
extensive reports from the different consultation committees have been published and 
will be referred to, several times, in the present work. Most ICS reports are designed 
for clinical aspects of UI, but the latest case definition of subjective UI is as simple 
as: Complaint of involuntary loss of urine13. This definition was established in 2002 
when ICS provided new definitions for lower urinary tract dysfunction, compatible 
with the WHO ICIDH-2 (International Classification of Impairment, Disability and 
Health) and the ICD10 (International Classification of Diseases)2. Before that, “the 
presence of a social or hygienic problem”, was included in the definition of UI, but 
since those concepts are very variable by subjects and causes confusions, they were 
removed. However, in the new definition, ICS recommends that UI should be also 
described by specifying relevant factors such as type, frequency and severity of UI2. 
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In the latest joint report on the terminology for female pelvis floor dysfunction, by 
ICS and International Urogynecological Association (IUGA) in 201013, eight 
different types of UI based on symptoms were defined. Among these, three are 
related to this dissertation, and defined as follows:  
Stress UI: Complaint of involuntary loss of urine on effort or physical exertion (e.g. 
sporting activities), or on sneezing or coughing.  
Urgency UI: Complaint of involuntary loss of urine associated with urgency. 
(“Urgency” replaces “urge” as the “accepted” terminology for the abnormal rather 
than the normal phenomenon of an urge to urinate)  
Mixed UI: Complaint of involuntary loss of urine associated with urgency and also 
with effort or physical exertion or on sneezing or coughing. 
These definitions for major types of UI are not much changed compared with the 
report from 20022.  
Regarding severity; as a relevant factor for describing subjective UI, there is no 
specific definition in the ICS reports. However, there are many studies that include 
data for severity of UI based on frequency and amount or volume of urinary leakage. 
One of the most popular methods is the Incontinence Severity Index (ISI) created by 
Sandvik et al8,14. This index, which is used in the publications for this dissertation, is 
based on self-report on frequency and amount of leakage, which later can be 
calculated by multiplying the values and categorized to 3 or 4 grades. This index will 
be explained later in the “Material and Methods” section.  
Despite of all modifications, the dispute about the definition of UI is still on. Some 
confusion arise from the ambiguity between researchers and clinicians and some 
other confusion arise from the translation of the definition in different languages15. 
For example, in the latest definition of UI, it is emphasized that instead of “Stress 
UI”, in some languages, “activity related UI” might be preferred to avoid confusion 
with psychological stress13. Variation in definition of UI can cause discrepancies 
among different epidemiological studies, even if the true prevalence and incidence 
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are the same. Holtedahl et al16 in a cross-sectional study, showed how the estimation 
of prevalence can distinctively change by different definitions in the same population. 
For example, while 42.7% of women in age group 50-54 reported UI as any 
involuntary leakage, only 16.0% of them could be confirmed with UI by the old 
definition of ICS (involuntary urine loss with social or hygienic problem).  
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3. Epidemiology of Urinary Incontinence  
In the last three decades much progress has been made in the understanding of the 
prevalence rates and establishing risk factors of UI. However, since longitudinal 
studies are necessary to investigate the incidence, remission and natural history of UI, 
and this type of study is time-consuming and expensive, less research on these 
matters has been conducted10. In this part of introduction, the focus is mainly on the 
epidemiology of UI in women. After reviewing the prevalence, the incidence and 
remission of UI will be reviewed. 
3.1 Prevalence 
Prevalence of UI in women has been studied widely in different geographic and 
demographic settings. The results of these studies show very different and wide-range 
estimates of prevalence. In a review of articles17-19, reported in 3rd ICI, the prevalence 
of UI in women, in 36 different population-based studies in 17 countries, showed a 
range from 5.0%20 to 69.0%21. Another systematic review22 showed a range between 
4.8 and 58.4%. Hunskaar et al. in yet another study7 compared the prevalence of UI 
in women in 5 different European countries; the range of estimated UI was between 
23.0% (Spain) to 44.0% (France). In a cross-national study23 the estimation of 
prevalence for women 18 years and older was reported 18.0%. However, generally 
most of studies report a prevalence of UI in the range of 25% to 45%.  
There are many different possible reasons for this variety in estimation of prevalence. 
Milsom et al.18 explain some of those reasons as follows; sampling frame, response 
rates, variation in definition of UI, types of UI, methodology of survey, cultural and 
language differences. To be able to compare epidemiological studies, all these 
reasons should be encountered. As an example, in 3 different large-scale studies, the 
prevalence of any urinary incontinence in women aged ≥ 40 was reported as 16.1%23, 
38.8%24 and 67.6%25. To understand the reason for differences in estimation of 
prevalence of UI, I briefly review these papers here.  
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The first study23 was a population-based, cross-sectional telephone survey of adults, 
aged 18 and over, in five countries (Canada, Germany, Italy, Sweden, and the United 
Kingdom). The study was conducted in 2005. Among 58139 individuals (male and 
female), 19162 agreed to participate (33% response rate). The 2002 ICS definitions of 
UI were used and for women aged 18 and over, the prevalence rate for any UI 
reported as 13.1%, and after adjusting the age for women 40 years old and older 
(n=8611), the prevalence calculated as 16.1%.  
The second study24 was a prospective, population-based survey in Belgium, and was 
conducted in 2011. Women aged 40 plus, who visited a general practitioner, for any 
reason, were invited to participate in the survey (no response rate was given). A self-
assessment questionnaire was used and one of the questions asked about the presence 
of incontinence. Data were collected on 7193 women, 38.8% reported any UI.  
The third study25 was a cross-sectional Internet survey, which was conducted in 
United States, United Kingdom and Sweden. The study was published in 2012. A 
total of 15861 women age 40 and plus participated in the survey (response rate for 
both men and women was 59.2%). Participants received equal of 2 US dollar as 
encouragement points. UI was defined as any urinary leakage during the last 4 weeks. 
Overall UI was reported in 67.6% of women.  
There were thus major differences in mode of administration of questionnaires, 
recruiting samples, response rates and methodology, plus differences in cultural 
backgrounds and definitions of UI provide probably these factors a wide range of 
estimation of prevalence of any UI in the surveys. One of the limitations of such 
studies is the use of self-reported incontinence, which increases the inaccuracy 
relative to objectively diagnosed UI23,26. The individual’s interest in the subject of the 
research may also affect the results, clearly indicated when the distribution of UI is 
different in non-participants compared to sample. Therefore, demographic differences 
between sample and source population should be shown in all studies.  
As an established finding, the prevalence of UI increases with increasing age6,10,19,27. 
An interesting finding, noted by several investigators, is a slight decrease of 
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prevalence of UI in middle-aged women, which is then followed by an increase 
toward the elderly6,10,28-30. A decrease in prevalence could happen due to treatment, 
remission or a decrease in incidence. A decrease in incidence could be the result of a 
biological effect or a reduction in the level of precipitating factors (e.g. sports or 
physical activity). As a biological effect, menopause, in some studies3-5,31, was 
considered as a possible cause for increasing the occurrence of UI. In contrast, many 
cross-sectional studies show that the prevalence of UI does not increase or decrease 
with natural menopause31-36. Some studies show evidence that stress UI is more 
related to menopause than urgency UI3,21. However, since menopause is a long 
process, evolving during several years, it is difficult to establish its relationship to 
UI18.  
There are several studies on epidemiology of UI in Norway; I am going to review 
some of them, as they are related to this dissertation.  
In 1993, Sandvik et al8 conducted a study aiming to validate a simple Severity Index 
of UI in female with a subsequent epidemiological survey.  They created the Index by 
multiplying the reported frequency (four levels) by the amount of leakage (two 
levels) and validated the Index against pad weighing test. Women with UI, who were 
referred to a gynecological clinic, were interviewed for calculation of Severity Index, 
and half of them performed pad-weighing test at home. Comparing the results 
between these two tests showed a significant correlation. In the epidemiological part, 
1820 women aged 20 or more were studied and an overall prevalence of UI of 29.4% 
was reported. The overall prevalence was higher in the age groups 50-59 and 80+ 
years. Based on the Severity Index, 46.0% of women with UI were classified as 
having slight, 27.0% as moderate and 27.0% as severe UI. This study, for the first 
time, showed that there is a prevalence peak for UI in middle-aged women.  
In 1994, Holtedahl et al16 studied prevalence, incidence and remission of UI in 
women 50-74 years of age. Data were collected from 3 different North-Norwegian 
municipalities. A total of 698 women were invited by mail for two gynecological 
examinations with one-year interval. 507 women (response rate 72.6%) met for the 
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first consultation and 489 of women participated in the second consultation. Both 
participants and physicians filled out a questionnaire, containing questions about UI. 
Any UI was defined as self-reported urinary leakage of any kind and the prevalence 
was 47.3%. Two or more leakage episodes per month were defined as “regular” UI 
and the prevalence reported was 30.6%. The annual incidence of UI was reported to 
be 0.9%. Spontaneous remission was not reported and only 7 out of 59 women who 
reported UI, also reported remission as a result of medical treatment.  
Another major study6 in Norway was the EPINCONT study, which was performed in 
a county in Norway during 1995-97 as part of the large HUNT study in Nord-
Trøndelag. Everyone aged 20 years or more (n=47313) was invited and 74% of them 
participated in EPINCONT study and defined as source population of EPINCONT 
study. Among 80.0% (n=27,936) of women who answered the questions about UI, 
25.0% had urinary leakage6. The prevalence of significant UI, which was defined as 
moderate to severe UI (by Severity Index) and presence of at least some bother was 
7.0%.  Half of the incontinence was of stress type, 11% had urgency and 36% mixed 
incontinence. The EPINCONT study has since been the source for a long series of 
publications (i.e. parity 37-39, help seeking 40, diabetes 41-43 and lifestyle factors 44) 
Klovning et al45 compared the result of a web-based study on the prevalence of UI 
with results from the EPINCONT study. Women were invited to the survey by web-
banners, and those who selected to participate by clicking the banner, were 
redirected to another link with a short introduction about the survey and then an 
online questionnaire. During two months 1812 women were recruited from different 
websites. After applying same inclusion criteria, 1619 of women, age range 20-69, 
were included in the analysis. Crude unadjusted prevalence of UI was 20.0% while 
the same results in the EPINCONT study (age-range 20 +) was 25.0%6. Age-
adjusted prevalence rates of UI (5-year age categories) showed a lower prevalence 
rate in age groups 20-24 and 25-29, but a higher prevalence in other compatible age 
groups. The software used for this data collection had not the ability for controlling 
multiple entries of one individual. As Internet researches are more attractive for 
younger people, conditions that are more prevalent in old ages, may not be suitable 
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for Internet surveys so far. The study also concluded that the web-based surveys 
might not be suitable for estimating the prevalence of UI due to interest bias. But 
such studies may be well suited for recruiting persons for studying women with UI46 
Ebbesen et al47, in a study published in 2013, studied the changes in prevalence of UI 
in women in the Norwegian EPINCONT study. The study also used data from the 
second EPINCONT (2006-2008) and showed a 16.0% relative increase in prevalence 
of UI in the county of Nord-Trøndelag during 11 years. UI was defined as any 
involuntary loss of urine, and Severity Index was used for evaluation of severity. 
Some known UI risk factors, such as age, BMI, weight and parity, were suggested as 
some of the causes for increasing the prevalence of UI in this population. The study 
also reported the incidence and remission rate of UI, which will be discussed here 
later. 
3.2 Incidence and remission 
Incontinence is a dynamic condition18 with the possibility of remission 
(spontaneously or after treatment) and recurrence. The incidence rate is calculated by 
dividing the number of new cases by the number of continent women at baseline in a 
given time period. For calculation of remission rate the number of women who 
become symptom free is divided by the number of incontinent women at the start of 
study in the same given time period. Since the denominator for remission rate is 
usually much smaller than the denominator for incidence rate, the remission rate 
usually shows a larger percentage compared with incidence rate18.  
Annual incidence of UI is estimated very widely (0.9%-18.8%)48, which can be 
explained by several reasons such as different definitions or methodology of research. 
Studies that limited the definition of UI to “weekly UI”, has less variation in 
incidence (1.2%-4.0%) compared with studies with using “any” or “monthly UI” 
(0.9%-18.8%)48. Besides the definition of UI, there are other important points that 
should be kept in mind in any systematic review of incidence of UI, such as duration 
of study, survey method and outcome measures49. The length of a study has a 
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negative correlation with reported annual incidence rate48, it means that studies with 
shorter duration (1-2 years) may overestimate the annual incidence rate.  
In any cohort, for finding the incidence rate of UI, the population at baseline must be 
divided into continent and incontinent. However, some of the continent women at 
base line may be the subjects of remission, and based on the study design, they may 
or may not be counted as incident cases18. And even if the study is clear about this 
matter, some cases may be misplaced due to recall bias. It is also important to take 
types, severity and age groups into consideration when we compare the incidence rate 
between different studies.  
The interval between data collections is also very important. Cohort studies with long 
intervals like 5-10 years50 may report lower annual incidence than cohorts with 
reported 1 to 2 year follow-up27. The accuracy of data increases in cohorts with 
several waves throughout the study period. To have a better picture of incidence of 
UI, I am going to review studies published since year 2000, chronologically. Table 1 
also summarized the annual incidence and remission (if reported) of these studies.  
Moller51 followed 2860 women, aged 40-60 years in a longitudinal study with a 
baseline and a one-year follow-up questionnaire. UI was defined as any involuntary 
loss of urine occurring weekly or more. Incidence was defined as the proportion of 
women in whom symptoms started or increased from sometimes to weekly or more. 
Conversely, the rate of remission was defined as the proportion of women with 
symptoms occurring weekly or more at baseline in whom symptoms decreased to less 
than weekly and eventually ceased at one year follow-up. Overall incidence and 
remission were reported as 10.0% and 27.8% respectively. The baseline data gathered 
in 1996 and compared with other studies, the higher percentages of results, might be 
due to differences in the study design and UI definitions. 
Samuelsson46 studied 382 women, aged 20-59 years with a questionnaire and a 
gynecologic examination at baseline (1993) and a follow-up questionnaire after 5 
years (1998). UI was defined as any involuntary loss of urine. A 5-year incidence rate 
of 14.0% and a 5-year remission rate of 28.0% were reported. For the age group 30-
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39 the annual incidence was 3.5% while it was 2.9% for the age group 40-49; the 
remission was 8.5% and 6.4% for age groups 30-39 and 40-49 respectively. If they 
had monitored the women with repeated annual questionnaire the true 1-year 
incidence would probably be higher than the mean annual incidence rate because 
women who were continent at baseline and at follow-up might have had periods of 
incontinence during the follow-up interval.  
Sherburn52, with focus on association between UI and menopause, studied  438 
women aged 45-55 years. At baseline, women were interviewed by telephone and 
then they were interviewed annually, face-to-face at their home. UI was defined if 
they answered yes to the question about any problem with control of your urine in the 
past 2 weeks. Over the 7-year follow-up, the incidence rate was 35.0%. They found 
no significant association between UI and the transition to postmenopause. Women 
who experienced a surgical menopause had higher incidence of urinary incontinence 
than women in the other menopausal transition groups. Beside the small sample size 
and narrow age-span, the study lacks questions for determining the types of 
incontinence. 
McGrother53 studied about 12,000 women aged more than 40 years in UK at two 
checkpoints with one-year interval. The article was published in 2004. UI was 
defined as any leakage occurring monthly or more. Severity was assessed by 
multiplying frequency (i.e. yearly=1, monthly=2, weekly=3, daily=4) and volume 
(any leakage=1, damp=2, wet=3, soaked=4); and the final scores (1-16) were 
categorized to minimal (1-2), moderate (3-4), severe (5-9) and profound (≥10). They 
also defined age groups with 10-year age-span. The annual incidence of any UI was 
8.4% and 7.9% for age groups 40-49 and 50-59 respectively. The remission was 
26.9% and 25.5% respectively. 
Dallasso54 assessed the association between the development of stress UI and diet in 
women aged 40 years and plus. The study was conducted in 1998 and published in 
2004. With a follow-up after one year, 5816 women were included at baseline. 
Participants were considered to have stress UI if they reported leakage of urine with 
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laughing, coughing or exercise, with a frequency of at least several times a month 
during the previous 12 months. The results showed 9.3% and 7.2% incidence of stress 
UI in age groups 40-49 and 50-59 respectively. The incidence rate of stress UI was 
reported as highest in the perimenopausal group (40-49 years) and in the very elderly 
(80 years plus).  
Ostbye50 studied UI in a cohort study with 3 waves during 10 years. The study was 
started in 1991 with the second wave in 1996 and the last wave in 2001. A total of 
5322 women, aged 65 and plus were included at baseline. For women aged 65-74 
years at baseline, the incidence of UI was 14.3% and 18.3% in wave one and wave 
two respectively. The study confirmed that UI is a dynamic condition, with a 
relatively large number of both incidence and remission. The study did not 
distinguish between different subtypes of UI and there were no details on severity, 
duration, and impact of UI. As mentioned above, longitudinal studies on elderly 
people have a higher proportion of lost to follow up, due to high rates of mortality. In 
this study, also, to the extent that individuals who died or were lost between waves 
were more likely to develop UI than those who were followed up, the reported 
occurrence rates might be lower than the actual rate.  
Hagglund55 studied 248 women aged 22-50 years at two checkpoints with 4 years 
interval (1996 and 2000). At baseline, 118 women were incontinent and 130 were 
continent. The mean annual incidence and remission rates of UI were the same 
(4.0%). The majority of women (83.0%) reported unchanged UI after 4 years and 
77.0% of these women had stress incontinence. In age group 41-50 years, the 4-year 
incidence and remission was 18.0% and 13.0% respectively. Beside the small sample 
size, one of the limitations of the study was the screening question for UI: “For the 
present time do you have a problem with involuntary loss of urine?” which could be 
confusing for participants due to using the words “present time” and “problem”, thus 
causing misclassification error, and underestimation of the incidence rate.   
Wehrberger56 in a follow up of women aged 20-84 years after 6.5 years included 441 
women. The baseline data was gathered in 1999 and the second questionnaire was 
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sent in 2005. The mean annual cumulative incidence of UI was 3.9%, with the lowest 
rate (2.3%) in the youngest age group (29-39 years) and the highest (7.3%) in those 
aged 70 years or older. The mean annual full remission rate was 2.9% with no clear 
age dependency. More than half of women (55.6%) with a full remission had only a 
mild form of UI at baseline. After a multivariate analysis, they showed that urgency 
UI and age are correlated to risk of new-onset UI. The problem of following 
individuals over a prolonged time period is emphasized in this study, as almost 50% 
drop out rate was presented. This study should be interpreted with caution because of 
small number of cases, and since the study is not population-based, selection bias 
should be considered.  
Waetjen57 used data from the baseline (1995) and first five annual follow-up visits 
(up to 2001) from the American prospective cohort of the Study of Women’s Health 
Across the Nation (SWAN). The mean age at baseline was 45.8 years. The 
prevalence of incontinence was 46.7% and the average incidence was 11.1% per year. 
Most women reported stress, but a higher proportion developed urgency UI (15.9% 
vs. 7.6% at baseline). This study was among the first to examine the prevalence and 
incidence of UI in a racially/ethnically diverse group. The study also showed that 
while parity was associated with increased odds of prevalent stress and mixed UI, it 
was not an important factor in the development of any type of incident incontinence 
over the 5 years of follow-up. This novel observation suggested that the impact of 
parity on incontinence presents in the reproductive years, while incontinence that 
develops in midlife is not related to child bearing.  
Townsend58 in a prospective analysis of 64650 women aged 36-55 years in Nurses’ 
Health Study II (NHS II), established a 2 years follow-up (2001 and 2003). The 
overall 2-year incidence of UI was 13.7%, which corresponds to an average incidence 
of 6.9% per year. Incidence generally increased through age 50 and then declined 
slightly in older women. Among women with incident incontinence at least weekly, 
the incidence of stress incontinence increased through age 50 years (2-year incidence 
1.7%) and the incidence of urgency UI was stable across age groups (2-year 
incidence 0.4%). Complete remission of symptoms occurred in 13.9% of women with 
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incontinence at baseline. Remission was more common in women with frequent than 
with occasional incontinence. Since the participants in this study are a selected group 
of largely Caucasian health professionals, the incidence estimates may not be 
generalizable.  
Goode59 determined the incidence of UI over 3 years in a community dwelling older 
adults. The study was published in 2008, but the study was conducted in 1999-2001. 
UI was defined as any degree of incontinence occurring at least once a month in the 
last 6 months. 490 women aged 65 years and plus were included at baseline. The 
study had 3 annual waves with the incidence rates of 15.0%, 13.0% and 8.0% in the 
first, second and third wave respectively. Cumulative incidence rate in 3 years was 
29.0% (general annual incidence rate: 9.7%). One of the limitations of the study is the 
definition of UI, for this age group, which is not standard and may cause recall bias. 
The study is also small in sample size and the high rate of mortality in this age group 
may underestimate the incidence rate.  
Komesu60,  studied 11591 women ≥ 50 years and have reported an annual incidence 
of any UI between 3.2% to 8.5% for fifth vs. ninth decade. The baseline data for this 
study was gathered in 1993 and the follow up data in two waves with four years 
interval (1998 and 2002). They determined any UI by asking the question, “During 
the last 12 months, have you lost any amount of urine beyond your control?”. To 
determine the severity of UI they asked women a question about how many days in 
the last month they lost any urine. Mild UI was defined as ≤5 days/month, moderate 
UI as 6-15 days/month and severe UI as ≥15 days/month. 45.8% of women with 
severe UI reported improvement (change to moderate, mild or continent) over 4 
years; women who got medical treatments were not excluded. Types of UI were not 
included in the study. Since the study included elderly subjects, mortality may have 
affected the incidence. Recall bias and non-standard questions may also count as 
limitations of this study.  
Melville61 et al in a study published in 2009, used data from a population-based 
cohort to find the association between major depression and UI. Accumulated 
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incidence of UI among 5036 continent women (age range 27-76, mean age 59.3) at 
baseline (1996-97) after 6 years was 21.0%. UI was defined as any loss of urine 
beyond control in the past year and ≥1 day of incontinence in the past month. The 
definition of UI, wide age range, and recall bias may be considered as some of the 
limitations of this study. 
Ebbesen47 et al evaluated the incidence of UI in a large population of women (age 
20+) participating in the EPINCONT study, by two data points with 11 years interval. 
This article was published in 2013. UI was defined if a woman answered 
affirmatively to the question: “Do you have involuntary loss of urine”. The 
accumulative incidence of any UI was 18.7% (1.7% annual incidence) and the 
remission 34.1% (3.1 annual remission). Women in age group 20-39 reported higher 
incidence and higher remission than other age groups (40-54 and 55+). The results 
show similarity with other large studies62.    
Maserejian63 in a recently published study (2014), analyzed data from Boston Area 
Community Health Survey (BACH). 3201 women aged 30-79 were included in the 
baseline and after 5 years 2534 women completed the follow up. UI was defined by 
answering the following question: “Many people complain that they leak urine (wet 
themselves) or have accidents. In the last 12 months, have your leaked even a small 
amount of urine?”63. The incidence was reported as 14.1% for at least monthly and 
8.9% for at least weekly urinary leakage. 44.2% of women with weekly UI at 
baseline reported complete remission and 14.1% reported partial remission to 
monthly UI after 5 years. 
Legendre et al64 recently (2014) published the result from the French GAZEL cohort 
on incidence and remission of UI at midlife. The study included 4127 women aged 45 
and over in 1990 and followed them with a questionnaire every three years up to year 
2008 (6 waves). UI was defined by answering, “Yes” to the question: Do you have 
trouble holding your urine? The results included 3828 women who responded ≥2 of 
questionnaires.  A total of 941 (24.6%) women, with mean age 48.9 year reported UI 
at the baseline. The annual incidence and remission rate of UI were 3.3% and 6.2% 
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respectively. Aging and weight gain were reported as the only factors associated with 
persistence UI, while menopause onset reported as positively associated with UI 
remission. The study has a different definition for UI than ICS definition of UI in 
2003. Type and severity of UI were not investigated. 
These studies are summarized in Table 1. Each of the studies brings a piece to the 
puzzle of incidence and remission of UI in middle-aged women. However, more 
longitudinal studies of incidence and remission are needed to investigate the causal 
factors and predictors for incidence and remission of UI.  
Table 1 
Summary of studies on incidence and remission of UI, published since year 2000 
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3.3 Natural history of urinary incontinence 
By studying the natural history of UI, we can get a better understanding of the 
etiology, progression, and contribution of risk factors. Causal understanding of the 
disease is an important factor for disease prevention and control65. Data are needed 
regarding the transition from continence to various levels of severity and types of 
incontinence4,5,10,66.  
Since urinary incontinence may be reported as a symptom in epidemiological studies 
(rather than a clinical condition), studying the natural history of UI may be 
approached differently. Social, cultural and even personal insights due to age may 
also affect an individual’s report. Study of UI in a female population has some 
challenging aspects. The female life cycle, from childhood through the fertile years, 
pregnancy and childbirth, the menopausal years and beyond include many unique 
differences that need especial attentions for studying health status. Here, we focus 
only on middle-aged women. During middle age a woman may experience UI in 
different ways, it can be a short-term experience with spontaneous remission, or a 
serious problem for the rest of her life. To be able to explain the natural history of UI, 
defining new-onset UI and its development over time by types and severity is 
necessary.  
Concomitant conditions may affect studies of UI. Many women with UI also have 
pelvic organ prolapse. One in five women will undergo surgery for incontinence or 
prolapse during her lifetime67 and surgery for prolapse is three times more common 
than for stress incontinence in the US68. These numbers underestimate the frequency 
of pelvic organ prolapse itself, since many women with this disorder are treated non-
surgically or do not receive (or wish to receive) treatment at all, also prolapse is 
commonly a symptom-free disorder. Roughly one in five women with UI also have 
fecal incontinence (FI)69. Although UI could reduce the quality of life, FI is even 
more devastating70, and the particularly embarrassing nature of this disorder makes 
screening imperative in assessment of women with UI.  
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Many longitudinal studies provided information on risk factors for new-onset UI but 
studies on the progression or resolution of existing incontinence are scarce. This 
distinction is important since prognostic risk factors may differ from risk factors for 
incident disease. In addition, only a few groups have reported change by incontinence 
type and/or severity. Previous studies that followed the course of UI are mostly 
clinical or in related to one of the risk factors, for example it was showed that 
overweight middle-aged women have a higher risk of developing UI57, or women 
with diabetes have significantly more weekly UI than women without diabetes71. 
Some of the studies are interventional e.g. Townsend72 examined the association of 
hormone therapy and incident UI in postmenopausal women, in Nurses’ Health 
Study. The result showed that the odds ratio of incident UI was 1.39 in current users 
of menopausal hormone therapy.  
Thom et al73 investigated the factors that predict incidence progress, regression and 
resolution of UI in diverse women participants in a prospective cohort. At baseline 
2109 women aged 40-69 were included and after 5 years 1413 of them completed the 
second part of survey. The frequency of UI was categorized as less than weekly, 
weekly and daily. At baseline 1027 women (72.7%) reported at least 1 episode of 
leakage in the last 12 months. After 5 years, 536 women (38.0%) reported a change in 
continence status. 12.0% of them reported a progress in UI, 9.1% reported resolution, 
8.6% regression, and 8.4% reported a new-onset UI. The annual incidence of UI was 
reported as 6.0%. The study showed an increase in the incidence of urgency and 
mixed UI, while the incidence of stress UI was decreased in the middle age group. 
This finding was consistent with previous studies showing a decreased prevalence of 
stress UI with age in middle-aged and older women38,66,74,75 and in inverse association 
of age with new stress incontinence74. Remission rate was about 2.4% per year, which 
was at the lower end of previous reports18,59,74,76. The study provided additional 
valuable information on the dynamic change in UI. 
Searching PubMed for UI and natural history gives us a limited number of articles, 
which are mostly clinical. This limitation is even more when we add “women” or 
“middle-aged women” to this search. Longitudinal studies on natural history of UI 
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have to span several years because of the slow progression of the condition. Costs of 
longitudinal designs and difficulties in following a substantial number of individuals 
over several years are the main reasons for the paucity of longitudinal data on this 
topic. However, the high prevalence of UI in women, particularly in perimenopausal 
period, underlines the importance of a thorough understanding of the natural history 
of this condition.  
3.4 Risk factors 
My own research has not included risk factors, but as a part of epidemiology, I have 
chosen to give a brief account of current knowledge in this regard. 
Risk factors for UI in women have been investigated in many epidemiological 
studies. Most of these studies are cross-sectional and even if they reported a wide 
spectrum of risk factors, they cannot conclude about causality. Longitudinal studies, 
on the other hand, have a better possibility to assess causal risk factors for incident 
UI, but still they may not be able to measure confounding factors. However, some of 
the risk factors are well accepted, like age, obesity, parity and hysterectomy9,18,22,77,78. 
In studying the risk factors of UI in women, most of the studies focus on older people 
or on women during pregnancy; and put rather less focus on the risk factors among 
middle-aged women79. One of the studies79 with focus on risk factors in middle-aged 
women was published in 2006. This cross sectional study used data from 83355 
women (age 37-54) in Nurses’ Health Study II, and the major UI risk factors in 
women were reported as: white race, high BMI, parity (compare to nulliparous 
women), current smoking, diabetes mellitus and hysterectomy79.  
The latest edition of the book “Incontinence” from the 5th International Consultation 
on Incontinence (ICI)80 has a comprehensive review of risk factors of UI in women48. 
ICI ranked the risk factors by level of evidence (LE), developed by Oxford Centre for 
Evidence-Based Medicine. Table 2 shows the different categories of UI risk factors 
based on LE from ”Incontinence” book. LE1 indicates an established risk factor or 
highly evident, and LE3 indicates a suggested risk factor, which has not been 
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established as a proven etiology of UI. LE2 is the level in the middle, and is usually 
based on results from good quality cohort studies.  
Table 2 
Risk factors for UI, categorized based on level of evidence (LE)48 
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Several observational studies have showed that white, non-hispanic women are at a 
considerably higher risk for UI than black or Asian women57,81. Pregnant women who 
go through the labor and have vaginal delivery have higher chance to get UI than 
women who have C-section37,82-84, however, the strength of association for this factor 
is substantially reduced by age34,39. Obesity is probably the most established general 
risk factor for UI in women beside age85,86, and it especially predisposes women for 
stress UI. It is also reported from interventional studies that weight reduction, even 
moderately, can improve the symptoms of UI87-89.  
3.5 Impact and consequences 
UI is a very costly condition for both society and individuals. Any incontinence is 
associated with decreased health-related quality of life. Thus, effective prevention 
and treatment of UI may decrease routine care costs and improve quality of life. In 
this part, I review some articles on economic and other impacts of UI.  
Wilson90, in 1995, estimated the annual direct cost of urinary incontinence in the 
United States as $16.3 billion, including $12.4 billion (76%) for women and $3.8 
billion (24%) for men. Costs for community-dwelling women ($8.6 billion, 69% of 
costs for women) were greater than for institutionalized women ($3.8 billion, 31%). 
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Costs for women over 65 years of age were more than twice the costs for those under 
65 years ($7.6 and $3.6 billion, respectively). The largest cost category was routine 
care (70% of costs for women), followed by nursing home admissions (14%), 
treatment (9%), complications (6%), and diagnosis and evaluations (1%).  
Doran91 estimated the economic cost of UI in community-dwelling Australian women 
aged 18 years and over for the year 1998. The total annual cost of this UI was 
estimated at $710.44 million, or $387 per incontinent woman, comprising $338.47 
million in treatment costs and $371.97 million in personal costs. An estimated 60% of 
women with incontinence in 1998 were aged 40 years or over. Assuming the 
prevalence of incontinence remains constant and, allowing for inflation, they 
projected that the total annual cost in 20 years' time will be $1267.85 million, 93% 
($1.18 billion) of which will constitute costs associated with women aged over 40 
years. Subak92 reported $ 900 individual annual cost of severe UI in women aged 45 
years and more in 2006. 
There are no recent data on the cost of UI in Norway or Scandinavia. Previously, in 
1994, the National Insurance Administration (RTV) of Norway reported an 
approximately cost of NOK 200 million on incontinence pads (USD 7 per 
inhabitant)93. In 1990 it was estimated that managing UI in Sweden cost almost 2 
billion SEK, equal to two per cent of the total health expenses (USD 38 per 
inhabitant)26.  
Minassian94 (2012) also explains the iceberg of health care utilization in women with 
UI. Despite of the high prevalence of UI, seeking for help is low; it may be due to 
lack of knowledge of available UI treatments, or considering UI as a natural part of 
ageing, or lack of the necessary medical interventions94,95 
Coyne96 et al (2014) in a systematic review, divided the total economic burden of 
urgency UI in three different categories: direct, indirect and intangible costs. Direct 
costs are the costs of diagnosis, treatments and routine cares such as pads, diaper, 
laundry, dry cleaning and other comorbid conditions. Indirect costs are related to the 
economic burdens on individuals’ work productivity due to sick leaves or diminished 
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job performance and mortality costs. Intangible costs are related to pain and suffering 
and also decrease in quality of life. This systematic review included 7 studies. The 
review showed annual direct costs in United States in 2007, for adults aged ≥25 
estimated as 65.9 billion dollars, the projected costs for 2015 was estimated up to 
82.6 billion dollars.  
In a recent article, Milsom97 et al (2014) did a systematic review on economic burden 
of urgency UI. Among 11 studies included in this review, 4 of them belong to Europe 
and Canada; the estimated annual cost of urgency UI was reported close to seven 
billion euros in Canada and 5 European countries (Germany, Italy, Spain, Sweden 
and United Kingdom) in year 200598. The study suggests a 25% increase in urgency 
UI costs in the next decade, because of the aging of the population and particularly 
due to increasing direct costs for nursing homes.  
Beside the economic impact, several studies showed that UI can cause symptoms 
related to social, physical, and emotional functions, which can decline the quality of 
life (QoL) of affected person99-102. However, assessment of QoL is a 
multidimensional concept and different studies focused on different outcomes with 
different methods for measuring QoL and so far, no standard questionnaire on QoL of 
women with UI is available103.  
The social impact of UI is highly individual and complex104. Research has shown that 
the relationship between women’s perceived impact of incontinence and objective 
measures of its severity are complex and not directly proportionate105. Qualitative 
studies suggest that women’s perceptions of impact of UI may change over time106 
and women who have experienced incontinence for a longer period of time are being 
less troubled by it107. Others suggest that middle-aged women’s perception of the 
impact of UI on their lives may be different to older women’s perception because 
middle-aged women may have experienced symptoms for a shorter period of time 
and are more likely to be more socially active, making them more likely to rate their 
symptoms as severe84. Some conditions like depression may impact UI or act as a risk 
factor108. Comorbidity of severe depression and UI may affect the degree that the 
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patient perceives incontinence, and lead to lowering quality of life and functioning109. 
It has also been reported that the incidence of depression is analogous to the degree of 
incontinence, as well as to the degree of social isolation and QoL61. Types and/or 
severity of UI also affect the impact of UI on QoL. A recent study shows that mixed 
UI, due to more severe symptoms, has a stronger effect on of QoL110. Bartoli102, in a 
systematic review, asks for increased awareness among clinicians for patients’ QoL, 
especially those with urgency component of UI. Overall, several aspects should be 
kept in mind for evaluation of QoL in individuals with UI.  
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 Aims of the study 
The present dissertation is aimed at contribute to the knowledge about 
epidemiological questions about UI in middle-aged women. In this regard we used 
data from a prospective cohort that will be presented in detail later. Separate sub-
studies (Papers I-III) were undertaken as follow: 
Paper I: To evaluate the representativity of the Cohort compared with the source 
population (HUSK). The study estimated the prevalence of UI by type and severity in 
baseline and also presented the methodology of the Cohort. 
Paper II: To investigate the prevalence, incidence rate and remission rate of UI in 
middle-aged women including type and severity. We especially wanted to search for 
a possible early prevalence peak in this age group, and determine how it was 
influenced by changes in incidence and remission rates. 
Paper III: To investigate the natural history of UI in middle-aged women by type 
and severity of new-onset UI.  
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4. Material and Methods 
The Hordaland Women’s Cohort is based on one of the surveys in the Hordaland 
Health Studies, known as HUSK, which is also a part of a group of large-scale 
national health surveys, known as The Cohort of Norway (CONOR). The idea of 
CONOR was generated in the early 1990s. All universities, The National Institute of 
Public Health, The National Health Screening Service and the Cancer Registry 
discussed the possibility of CONOR as a national representative cohort. In 1994, the 
Ministry of Health selected the Steering Committee for the CONOR collaboration111. 
In Hordaland County, the University of Bergen in collaboration with Hordaland’s 
Municipal Health Service and the Norwegian Health Screening Service (now part of 
the National Institute of Public Health) conducted the Hordaland Health Studies.  
The Hordaland Health Studies are composed of two baseline data sets. First study 
was conducted in 1992-93, known as The Homocysteine study. This study included 
two main age groups; all individuals in Hordaland County born between 1950-52 and 
also individuals born between 1925-27.  
The second study, after establishment of the CONOR, was conducted in 1997-99 and 
is known as HUSK. In HUSK, beside the participants in the Homocysteine study, all 
individuals in Hordaland County born between 1953 and 1957 (n=29335, aged 40-44 
at the time of data collection) were invited to the study. For this age group, a 
questionnaire and an invitation for a health check-up were sent to them and 63.0% 
(n=18581, male=8598, female=9983) answered the questionnaire and came to clinical 
examination. A randomly selected 65% of women at screening stations got an 
accessory questionnaire, with a comprehensive part on lower urinary tract symptoms 
(LUTS). They were asked to fill it at home and send it back by post. We used data 
from this accessory questionnaire for some analyses in the Hordaland Women’s 
Cohort.  
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4.1 The Hordaland Women’s Cohort 
From this point, the Hordaland Women’s Cohort will be referred as “the Cohort” in 
this dissertation. 
4.1.1 Sampling and Participants 
The female population aged 40-44, participating in HUSK, is the source population of 
the Cohort. In order to find the necessary sample size, within a margin of error not 
greater than ±3% (c = 0.03), and assuming 50% hypothesized possibility for UI 
(p=0.5), the sample size (ss) with 95% confidence level (Z value = 1.96) was 
calculated by: 
 
Sample size for finite population (pop) of women in HUSK was calculated by 
following formula: 
 
By this calculation at least 900 women should remain in the Cohort after 10 years. 
Based on 5% annual attrition rate, at least 1501 women should answer the 
questionnaire in the first wave. Since the response rate for women in the HUSK was 
70%, at least 2150 women should be asked to join the Cohort. Of all invited, 3453 
female participants in HUSK, aged 40-44 were randomly selected, based on the last 
digit of their Norwegian Personal Number1. Of these, 2331 (67.5%) met at the 
screening stations and 2230 (95.7%) women consented to take part in the Cohort. A 
brief summary of these numbers is shown in Fig 1. 
                                            
1 In Norway everybody had a personal number and it makes Norway very suitable for community-based surveys. The 
personal number has 11 digits, which is composed of the date of birth (DDMMYY), a three digit individual number (the 
third digit shows the gender), and two check digits.  
ss =
Z 2 *(p)*(1− p)
c2
ss =
ss
1+
ss−1
pop
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Fig 1 
The Cohort sample size (n=2230) related to source population (n=9983) and total 
population (n≈14000) of women aged 40-44 in Hordaland 
 
 
4.1.2 Questionnaires 
In Paper I, we used the HUSK accessory questionnaire, which contained a major part 
on LUTS, for baseline analysis of UI. The LUTS part of questionnaire had a total of 
10 questions, the first 4 questions were general as follow: 
1. During last 12 months, have you ever had problem with acute burning 
sensation, pain or unpleasant feeling during urination? 
2. How often you urinate during a day? 
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3. Do you wake up during the night for urination? How often? 
4. Do you usually feel your bladder is empty after urination? 
The fifth question, as the entrance question for UI: 
5. Do you have involuntary urinary leakage?  
(If yes, please answer the following questions) 
6. How often do you have urinary leakage? (Less than once a month, ≥ 1 time(s) 
per month, ≥ 1 time(s) per week, Every day and/or night) 
7. How much leakage of urine do you have each time? (Drop or little, Small 
splashes, Bigger amount) 
8. Do you have urinary leakage with coughing, sneezing, laughing or lifting 
heavy objects? (Yes/No) 
9. Do you have urinary leakage during strong desire for urination? (Yes/No) 
10. How long have you had urinary leakage? (Less than 5 years, 5-10 years, more 
than 10 years) 
Source of data in Paper II and III is the questionnaire, which was designed for 
several follow ups of the Cohort.  This questionnaire has a simple design, easy to 
understand and easy to answer, and has 4 major parts: 
- Health, lifestyle and physical activity 
- Contraception and menopause 
- Urinary conditions 
- Consumption of any kind of medicine (prescribed or non-prescribed)  
The details of the questionnaire are explained in Paper I and some examples of the 
questionnaires are available in the Appendices of this dissertation.  
The questions in the 3rd part of the questionnaire (urinary conditions), in 6 different 
waves of the Cohort, have been used for the analyses of data in the present 
dissertation.  
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4.1.3 Definition of UI and its severity 
In Paper I, any UI was defined by including everyone who answered “Yes” to the 
entry question OR answering confirmatively on frequency, type and volume of 
leakage, even if they answered “No” to the entry question.  
In both Paper II and III, we used the Incontinence Severity Index (ISI) for definition 
of UI. ISI was created by Sandvik et al8,14, and is based on information about the 
frequency and amount of leakage. The frequency of UI can be scaled in reply to “how 
often you have urinary leakage?” as follows: 
None=0, less than once a month=1, more than once a month=2, more than once a 
week=3 and every day and/or night=4 
The amount of leakage can be scaled in reply to “how much leakage of urine you 
have each time?” as follow 
None=0, drops=1, splashes=2, big amount=3 
By multiplying the grades of frequency and amount, ISI was calculated and 
interpreted as None (0), Slight (1-2), Moderate (3-6), Severe (8-9) or Very severe 
(12). 
In Paper II and III, the definition of UI was done by use of ISI. Continent women 
were defined as ISI equal to zero, even if they answered affirmative to the entrance 
question. All the women with slight to very severe UI, based on ISI, were defined as 
urinary incontinent. Due to small number of cases with “very severe” UI, we 
combined this group and “severe” group into one group for the analyses.  
We also defined the women with UI as having a significant or non-significant UI. For 
this we used the question: How bothersome is your urinary leakage? The answers 
were dichotomized to “Non-bothersome” in case of choosing one of the first two 
choices (no problem at all, not much a problem) and “Bothersome” for the last two 
choices (some problems, very problematic). Based on severity and bothersomeness 
we defined significant UI as women with bothersome moderate to severe UI (Fig 2). 
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Figure2  
Calculation of Incontinence Severity Index and definitions of UI and Significant 
UI 
 
4.1.4 Types of UI 
In all three Papers types of UI were determined by the same questions in HUSK and 
the Cohort questionnaires. Women with stress UI were defined by answering “Yes” 
to involuntary loss of urine with coughing, sneezing, laughing or lifting heavy items. 
Urgency UI was defined by answering “Yes” to involuntary loss of urine connected 
to a sudden and strong desire to void. Mixed UI was defined by answering, “Yes” to 
both questions. And in case of having UI and answering “No” to both questions, they 
were categorized as non-classified.  
4.1.5 Paper I 
Paper I was published as the study protocol, to be used as the reference for further 
publications of the Cohort. This paper also evaluated the representativeness of the 
participants, compared with the source population in HUSK. Demographic variables 
(e.g. marital status, income, BMI, lifestyle, etc.) and urological characteristics were 
compared between the participants (n=2230) and the rest of women in HUSK who 
were not in the Cohort.  
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4.1.6 Paper II 
Data for this paper were based on data from six different waves of the Cohort and 8 
age groups (Table 3). Participants in the first wave were 41-45 years and in the sixth 
wave they became 51-55 years; it makes the total age span as 41-55 years. We 
defined 8 age groups with age span of two years in the first 7 groups and age 55 
solely in the last one allowing each woman to contribute to the data sets more than 
once, depending on their age, but only once in each age group. We defined two data 
sets; the first data set includes all data in all 6 waves. 
Table 3  
Age of the women while participating in groups by their age in different waves  
 )&,'*
A>8A? A@8AA AB8AC AD8AE AF8B= B>8B? B@8BA BB
>*+.- A> A? A@ AA AB           
?%.-   A@ AA AB AC AD         
@).-     AB AC AD AE AF       
A+.-       AD AE AF B= B>     
B+.-         AF B= B> B? B@   
C+.-           B> B? B@ BA BB 
 
For more sophisticated analyses, we analyzed the second data set, which included 
only women who answered all six questionnaires (complete data set). Women who 
did not answer one or more of the questionnaires were excluded. This “complete” 
data set was used to find the incidence and remission of UI.  
All women with ISI equal to zero were defined as continent and also as the risk group 
for being incontinent. Remission was defined as a change from “any UI” to continent. 
Type and severity of UI with 95% confidence interval were calculated in these 
analyses.  
For each data set, we calculated the prevalence of UI for all and each of age groups. 
We also calculated the prevalence for types and severity of UI and compared it 
between age groups. All the prevalence values were also compared between the two 
data sets.  
 53
4.1.7 Paper III 
In this paper we analyzed the natural history of UI in two steps; first the continent 
women at baseline were followed during 10 years in next 5 waves of the Cohort. For 
the second step of analysis, the women with new-onset UI, by type and severity, were 
defined and followed for the next 2 waves (if available). The exclusion criteria were 
lack of data in follow up waves or women who visited a doctor for UI. By this we 
obtained a continuous data set with four registrations during six years (from continent 
to new onset UI and 2 follow-ups). Based on the existence of UI in follow-up waves, 
the women were defined in 3 different subgroups (A, B and C). Subgroup A had no 
UI in two following reports, subgroup B had only one UI report in following reports 
and subgroup C had UI in both following reports (Fig 3). 
Figure 3  
Definition of Subgroups in analyses of results in Paper III 
  
In this paper, the first report of new-onset UI was compared between these 
subgroups, and exclusively for subgroup C, the first and last report of UI were 
compared for changes in types and severity. The algorithm of changes by type of UI 
in two follow-ups was made to visualize the interchanges between type and severity 
of UI.  
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4.1.8 Ethical approval 
The Cohort was approved by the Norwegian Data Inspectorate (Norwegian data 
protection authority) and Regional Committee for Medical Research Ethics. This 
approval allowed us to access the full 11-digit personal identification number for 
necessary merging and extending data with other sources (e.g. different national 
registries). All personnel and staff involved in the survey are bound by an oath of 
confidentiality.  
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5. Summary of Results 
The response rates, in all waves of the cohort, were much higher than the anticipated 
calculated response rates. Fig 4 shows the response rate during different waves and 
compares it with the anticipated response rate (calculated by the power calculation).  
Figure 4 
Comparing the number of participants in different waves (year) with the 
anticipated numbers by power calculation 
 
During 10 years, 17 (0.8%) women died, 12 (0.5%) women emigrated from Norway 
and 37 (1.6%) women asked for withdrawal from the survey. We also had some 
missing data; in the first wave 2229 questionnaires were sent instead of 2230, other 
missing data are mainly due to changed or unknown postal addresses. For each wave 
two reminders were sent to non-respondents, except for the 6th wave, which had three 
reminders. Figure 5 shows more details on lost in follow-ups in the first six waves of 
the Cohort. 
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Figure 5  
Details on participations in different waves of the cohort 
 
5.1 Paper I 
In the first part of analysis we divided 9983 HUSK female participants into two 
groups as “in the Cohort” and “not in the Cohort” (Figure 6). Comparing the 2230 
women (mean age 41.9 year), who consented to take part in the Cohort, with the rest 
of the women in the HUSK (n=7746, mean age 42.1 year), we found no significant 
difference at inclusion regarding age, marital status, parity, body mass index (BMI), 
self-rated health, lifestyle and medical condition. However, the women in the Cohort 
had higher education and larger annual family income compared with the rest of 
women in HUSK. The differences were statistically significant (p=0.001 for 
education and p=0.018 for annual family income). Details of this comparison are 
showed in Table 2 in Paper I. 
A total of 5320 female participants in HUSK answered the accessory questionnaire 
for LUTS. Among them 1920 women were participants of the Cohort. Figure 6 also 
shows the number of participants and non-participants for the LUTS questionnaire. 
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Prevalence rate of any UI was 24.8% and 28.9% in the Cohort women and the rest of 
women in HUSK (n=3400) respectively, and this difference was statistically 
significant (p=0.04). Distribution of type of UI also showed a significant statistical 
difference (p=0.05) between those two groups. Participants in the Cohort had a higher 
percentage of stress UI (55.4% vs. 51.8%) and urgency UI (11.0% vs. 8.1%) while 
the mixed UI (26.4% vs. 31.8%) showed a smaller percentage in the Cohort. 
Comparing other urological characteristics (dysuria, nocturia, duration of UI) 
between the Cohort group and the rest of women in HUSK showed no significant 
statistical differences. Some of the variables had a borderline non-significant p-value, 
like frequency of UI. Details on urological characteristics are showed in Table 3 in 
Paper I. 
Fig 6
Comparing the number of included participants in different parts of data analyses 
in Paper I 
 
5.2 Paper II 
In this paper the results were presented from analyses of two different data sets. First, 
we added data from all six waves  (age range 41-55). We recorded 5246 (40.2%) with 
“Any UI” and 960 (7.3%) with “Significant UI”. The second data set included 1430 
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women who answered the questionnaires in all 6 waves. In this data set we added 
data from 8580 questionnaires. The prevalence was 46.6% for “Any UI” and 8.0% for 
“Significant UI”. Both data sets showed a peak in the prevalence of UI in the age 
group 51-52.  
In analyses of the second data set for different age groups, the prevalence of any UI 
in the first age group (41-42) was 38.9%, which increased gradually with age up to a 
peak prevalence of 50.3% in age group 51-52 and then reduced in age groups 53-54 
and 55. Prevalence of significant UI showed almost the same pattern as any UI, but 
the absolute values of prevalence, for significant UI, in age group 41-42 (4.5%) was 
doubled compare with age group 51-52 (10.0%).  
The type and severity of UI were also analyzed in the second data set. Table 4 
compares distribution of types of UI between any UI and significant UI, for all ages. 
Table 4 
Comparing types of UI for distribution of Any and Significant UI in Paper II 
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Those distributions were also calculated for different age groups. In the matter of 
severity, most of women reported the UI as slightly severe, this proportion decreased 
by age. Distribution of moderate UI didn’t change much during the aging, but severe 
UI relatively doubled, from 5.0% in the first age group to 10.0% in the eldest age 
group.  
 In analysis of complete data set, while the remission of any UI showed an increasing 
pattern after age 51, the incidence showed a decreasing pattern, exactly where we had 
the peak of prevalence. The same pattern was also found for the significant UI. The 
total annual incidence, based on proportion of all women who reported UI during 10 
years (cumulative incidence), was 4.9%.  
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5.3 Paper III 
The results in this paper are based on data from 1274 continent women at the 
baseline. Fig 7 shows the number of women who had new-onset UI, wave by wave. 
During 10 years, a total of 514 women reported a new-onset UI, 449 women stayed 
continent, and 311 women were excluded due to missing data. The new-onset UI in 
89.3% of cases was reported as slight UI, with the majority (49.8%) of stress type.  
Only 10.0% of new-onset UI was reported as moderate or worse. 
Fig 7 
New-onset UI for each wave 
 
We could follow 337 women with new-onset UI in three pre-defined subgroups over 
next 2 waves (Figure 3). The distributions were 29.8% (n=100), 33.3% (n=112) and 
36.9% (n=125) for subgroups A, B and C respectively. Type distribution of new-
onset UI showed no significant difference between subgroups A and B or between 
subgroups B and C. But it was a significant difference between subgroups A and C, 
whit a higher proportion of non-classified UI in Subgroup A versus a higher 
proportion of mixed UI in Subgroup C.  
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More than 50% of women in subgroup A had a stress UI. Distribution of urgency, 
mixed and non-classified UI were 12.0%, 15% and 20% respectively. 95% of women 
reported “slight” UI and the rest reported only “moderate” UI.  
Comparing the type and severity of new-onset UI with the second report of UI in 
Subgroup B is summarized in Table 5 (non-classified UI is not shown). The 
distributions of new-onset UI were 58.1%, 13.4% and 16.1% for stress, urgency and 
mixed UI respectively. In the next report, the proportion of stress UI was reduced to 
46.5%, while urgency and mixed UI increased to 18.8% and 17.7% respectively. 
None of the changes were statistically significant. Severity of UI was reported as the 
same in 76% of women in both reports, 13.4% of women had an increase in the 
severity of UI and 7.1% reported a decrease. None reported severe UI in both reports. 
Table 5 
Comparing types and severity of UI in Subgroup B, Paper III   
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In subgroup C, women who reported at least one non-classified UI were excluded to 
simplify the complexity of algorithm of changes in types and severity of UI. As new-
onset UI, 56.7% of women reported stress UI, 15.4% urgency and 27.9% mixed UI. 
Type distribution in the last report (after 4 years) showed a reduction of stress UI to 
49.0%, while urgency UI increased to 21.2% and mixed UI had increased to 29.8%.  
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6. Discussion  
6.1 Dicussion of methods 
6.1.1 Design 
The Hordaland Women’s Cohort is a prospective longitudinal study, which was 
planned before 1997 for 15 years with every other year data collection up to 2012. In 
2008 after completing the sixth wave of the Cohort, adequate data were available for 
studying the set hypotheses. Since the Cohort was performed in a community-based 
population, all stages of severity and symptom expressions would be represented. 
This could uncover a part of the “iceberg” that is hidden outside the health care 
system and provide more insight in the natural history of UI. The longitudinal design 
is well suited for investigating incidence and remission, and also to follow the natural 
history of UI, which are all main issues in this dissertation. Multiple checkpoints with 
short intervals, plus including a very selective age group allowed us to focus on 
epidemiological details, especially the natural history of UI. The Cohort has high 
standards in these matters.   
The use of questionnaires allows the collection of data on many symptoms and 
conditions as well as medical background, and thus will give an opportunity to 
investigate the association between UI and several potential risk factors in the 
future18. Using the same questionnaire in different waves and following the same 
women increase the quality of the Cohort. 
6.1.2 Internal validity 
Internal validity depends on lack of systematic errors and some of such possible 
errors will be discussed here. 
Selection of subjects 
Selection bias results from improper methods of selection of subjects and it may form 
factors that influence study participation 112. A major advantage of using HUSK as 
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our source population is the fact that the whole population of the Hordaland County, 
born between 1953-1957, was invited, and that the survey achieved a fairly high 
participation rate (70.0% for women). The one-fifth random sampling of the Cohort 
lead to a relatively large sample of about 15.0% of the total female population of the 
Hordaland born between 1953-1957. Thus, the study is population based with low 
risk of selection bias.  
In this study, there may however be some minor selection biases. In Paper I, for 
socio-demographic data, we compared the participants in the Cohort (n=2230) with 
all the rest of women in HUSK (n=7746). For the urologic data we could compare 
86.0% (n=1920) of participants in the Cohort with only 44.0% (n=3400) of the 
women in HUSK. In the second part of analyses in Paper II, we have analyzed data 
from 1430 women, who contributed in all six waves. The enthusiasm for participating 
in all 6 waves is appreciated, but there is a possibility that those women were 
especially interested in urinary problems, or generally, more concerned about their 
health status. In Paper III, we used the first wave as baseline data and we followed 
1274 women who were continent in the first wave. In the second part of analyses for 
Paper III, for the 4-year follow-up data, we could follow only 337 women. We also 
excluded women who had visited a doctor for UI, and it may cause a selection bias, 
as it has been shown that severity of UI is associated with help seeking 40,113. Also 
since we aimed to follow up for next two waves, we couldn’t include women with 
new-onset UI from wave 5 and 6. 
Choosing a narrow age span, 41-45 years at the baseline, may be considered as one of 
the limitations of the study, whereas this was done on purpose to make the Cohort 
more exclusive for middle-aged women in the peri- and postmenopausal stages. We 
consider the narrow age span as one of the strengths of the study. 
The response rate 
Using power calculation, based on 70% response rate at inclusion and 5% annual 
attrition rates, we were supposed to recruit 2150 women at the baseline to have at 
least 900 women remain in the study after 10 years. Nevertheless in reality, the 
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participation rate was surprisingly high in the Cohort; we had much higher response 
rates than anticipated (Fig 4). After 10 years almost 1800 women still responded to 
the questionnaire. High response rate (87.0-93.0%) and very few dropouts thus added 
more strength to this study.  
As a matter of fact, participation rates for epidemiologic studies have been declining 
during the past 30 years, with even steeper declines in recent years 114.  The reason(s) 
behind the high participation rate in the Cohort is not clear. A recent study114, on 
declining participation rate in epidemiological studies, explains two central reasons 
for decreasing participation rate in a survey. First, refusing participation due to: 
- Increased number of requests for participate in studies 
-  Increased skepticism 
- Lack of interest in participating in studies that do not have personal advantage 
The other reason is a difficulty for finding potential participants. However, the high 
participation rate in the Cohort could be due to small influence of any of these 
negative factors.  
The questionnaire 
Epidemiological studies on incontinence rely on questionnaires and self-reported UI. 
The use of questionnaires is an effective tool for the collection of data from a large 
number of subjects but we are only able to register UI as a symptom and do not 
identify women with UI as a condition. The quality of the information gained this 
way is dependent on whether the questions measure what they intend to measure 
(validity) and that the measurements are reproducible (reliability). Moreover, several 
studies suggest that self-reported symptoms are valid when assessing incontinence at 
a single time point 115 and when examining changes in incontinence severity over 
time116. Validation studies of self-reports of type of incontinence compared with 
clinical diagnoses indicate that self reported stress and urgency symptoms tend to 
have good specificity but low sensitivity. In our study, the questionnaires contain 
many validated questions and the UI data set is in accordance with the 
recommendations from the 3rd ICI 78. However, at this point, an information bias 
should be kept in mind. Information bias, which occurs from errors in obtaining the 
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required information, is a problem among subjects already selected for a study 112. 
For example, women with UI may be more, or less, tending to answer the questions 
about incontinence than continent women. The direction of such a bias is difficult to 
predict. It should be noted that the definition of UI in Paper I was different from UI 
definition in Paper II and III. The HUSK questionnaire, which was used in Paper I, 
had an entrance question, which reduced the threshold for identifying UI and was 
intended to have a high sensitivity including symptoms of a wide range of severity. 
All women who answered “yes” to this question were defined as having UI, but we 
found out that some women who didn’t answer this question or even who answered 
“no”, still had answered confirmatively regarding frequency, volume and type of 
leakage. These women were also defined as UI cases in this study. Since the entrance 
question is in present tense, it may be confusing for the participant.  
In Paper II and III we didn’t use the entrance question to define UI, and the 
definition of UI was based on ISI≥1, which increased the threshold for identifying UI, 
but the results on prevalence of UI were not very different from the previous similar 
studies. Our aim was to detect all women who define themselves as leaking urine 
with amount and frequency more than “none”. A conceptual problem, at this point, 
could be the “self-diagnosis” of these parameters, which may vary considerably from 
woman to woman. This problem also exists for types of UI. 
6.1.3 External validity 
External validity or generalizability considers the extent to which the results of a 
study hold true for a population beyond those who participated in the research. One 
of the main advantages of population-based cohort studies is boosting external 
validity, thus, it is relevant to discuss the extent to which it can be achieved in real 
life. HUSK, as our source population, is representative of women aged 40-44 years in 
Hordaland, because 70.0% of total population was participated in this study. 
However, representativeness of the Cohort depends on eligibility criteria for 
inclusion, initial response of the sample, and the stability of the Cohort on follow-up. 
In addition, this quality cannot be achieved if there is lack of confidence in the 
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internal validity of the findings of the study. In Paper I, we showed that the Cohort is 
similar to source population in many aspects; thus, the external validity or 
generalizability can be considered as good. To generalize the result from the Cohort 
to the Norwegian population, we may need to compare demographic data from 
HUSK with nationally representative data like CONOR.   
External validity is also dependent on other aspects. The descriptive results from 
Paper II and III - prevalence, incidence, remission, and severity of symptoms - may 
differ from other “unselected” populations if there are differences in age distribution, 
ethnic diversity, inclusion of specific risk factors or other factors that influence the 
epidemiological parameters. One should for example not expect to find the same 
distribution of types and severity among incontinent women in clinical studies, as 
other studies have showed that only a minority of the incontinent women seeks help 
and the help-seekers have more severe symptoms40,113. In addition, due to different 
characteristics in different populations, the generalizability of our descriptive results 
may be fairly limited to Norwegian or Scandinavian women.  
Initial nonresponse of individuals chosen for inclusion in a population-based cohort 
study obviously limits the external validity. One of the important influences of 
nonresponse bias is the extent of which nonparticipation is associated with the 
outcome of interest117,118. In Paper II and III, in each wave of the Cohort, the matter 
of personal interest may change in women for different reasons like age, or severity 
of UI. Furthermore, the level of representativeness may also vary as a function of 
interactions between variables. For example, mixed UI, as a combination of existence 
of both stress and urgency symptoms may change the threshold of participation in a 
study. This matter will be discussed later in discussion of results in Paper III. 
6.1.4 Precision 
Precision in epidemiologic measurements corresponds to the reduction of random 
error. “Random” is used to denote unsystematic error as opposed to systematic error 
or bias. Random error can occur during data collection, coding, transfer, or analysis. 
Sampling error is a random error in sampling procedures, which causes a difference 
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between survey result and population value. Unlike bias, sampling error can be 
predicted, calculated, and accounted for. There are several measures of sampling 
error, like confidence intervals and p-values. Precision evaluation is linked to power 
calculation and a larger sample size means more power and increased precision. 
However, it should be noted that precision will be reduced when we analyze 
subgroups with small sample size, which can reduce the statistical power and increase 
the chance of Type II errors. Type II error is the error in testing a hypothesis of 
failing to reject a hypothesis when it is false and also describes possible errors made 
in a statistical decision process. For example in Paper II and III, studying women in 
eight different age groups, can reduce the precision due to reduction of power. This 
problem is even larger when analyzing smaller subgroups, for example the women 
with significant UI. 
6.2 Discussion of results 
6.2.1 Prevalence 
The prevalence of UI has been studied in many countries and in many settings. 
Differences in definitions and methodology make comparisons and reviews 
challenging as described in the introductory chapter. 
In Paper I, we used an entrance question “Do you have involuntary loss of urine?” to 
define any UI and the results showed that 26.3% of women in age range of 40-44 
years answered “yes”. This prevalence rate was somewhat higher than the 
EPINCONT study for the same age range (22.3%).  
After splitting these women into two groups as participants in the Cohort and the rest 
of them that did not participate in the Cohort, it was revealed that women who 
participated in the Cohort had a significantly higher UI percentage (28.9%) than the 
rest of women in the HUSK (24.8%).  Since the selection of women was truly 
random, there is no apparent reason for this difference. The very high response rate 
for the Cohort cannot explain this difference by bias alone. 
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In Paper II, we used the severity index (ISI) to determine the UI. The overall 
prevalence rate for any UI was 40.2%, which was in the suggested range of 
reasonable prevalence by ICI in 2004 (6). However, despite of the fact that we 
somewhat limited the definition of any UI by using ISI, the estimates of UI 
prevalence in Paper I was lower than Paper II. Two main reasons could explain this 
difference, first, the difference in definition of UI and second the methodology. It 
should be noted that we had different age ranges in Paper I (40-44 years) and 
in Paper II (41-55 years). In Paper II same women contributed to the results more 
than once in different waves depending on their age (but not more than once in each 
age group). Another possible reason for the prevalence differences could be the 
nature of questionnaires. In Paper II, the questionnaire was mainly focused on 
urinary symptoms, while in the accessory questionnaire from HUSK, used in Paper 
I, the UI problems was a minor part.  
By using the year of birth we categorized women by age. This categorization may 
draw a sharp line between different age groups but it may also include some women 
in a wrong age subgroup and cause some information bias. First, we calculated the 
prevalence of UI by using all questionnaires, and then we did the same calculation by 
using data from women who participated in all six waves. Comparing results from 
these two calculations showed that changing patterns of UI prevalence are the same 
in both, but the prevalence rate was slightly higher in the latter. Prevalence of UI 
steadily increased up to age 51-52 years and then started to decrease. Over a period of 
10 years, we found a relative increase of about 30% in prevalence for any UI and 
more than a doubling of significant UI. Compared with previous longitudinal studies, 
we have studied a rather narrow age span and we found the peak of prevalence in this 
age group more precise than previous studies. Some studies have found a peak in the 
prevalence of UI at age 50-55 years 6,30 and other studies at age 50-59 years 8,9. 
However they found different prevalence levels (27-60%). This difference may partly 
be due to the definition of UI and/or the age-range of subgroups 19. Our similar 
findings of a reduction trend of prevalence of UI after the peak, make us believe that 
it is a real epidemiological effect.   
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We defined “significant UI” by including both ISI and bothersomeness. This rather 
restrictive definition of significant UI was used before in the EPINCONT study, 
which reported 7.0% significant UI, similar to our result (8.0%). This definition for 
significant UI may include most women that should be denoted potential patients. 
Different from any UI, the changing patterns of prevalence of significant UI didn’t 
show exactly the same curves. As mentioned above, the nonparticipant bias, due to 
the matter of interest, may play the main role for higher percentage of significant UI, 
when we used all questionnaires. It means that some women may participate in some 
waves of the Cohort because they had more UI bothersomeness and vice versa. 
6.2.2 Incidence and remission of UI 
Results from Paper II revealed significant information about incidence and remission 
of UI. We used data from women who participated in all 6 waves and since we had 
the prevalence of UI from the same women in 10 years, we could study an accurate 
relation between changing pattern of prevalence with changing patterns in incidence 
and remission. Unfortunately, we didn’t have permission to connect our data from the 
Cohort to data from HUSK/LUTS questionnaire at the time of analysis and we used 
the first wave of the Cohort as the baseline to find incidence and remission rates. 
Incidence rate was relatively stable until the prevalence reached to its peak. Previous 
studies have also reported an incidence rate close to ours52,55,58. Not showed before, 
we were able to identify that the decrease in prevalence after the peak was due to a 
mutual effects of decreased incidence and increased remission rates. Also our overall 
remission rate fits well with previous literature27,46,51,58. However, the biological 
processes underlying the prevalence peak are still unclear.  
We also analyzed the type and severity of UI in different age groups. Our data was in 
favor of earlier concepts about the dynamic nature of UI with possibility for not only 
both remission and exacerbation, but also in shifting the types and severity 
distributions.   
In Paper III, the main focus was on natural history of UI. We used the same 
definitions for UI as in Paper II. One of the challenges in analysis of the results was 
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the high variability of changes in types and severity of UI from wave to wave. At the 
time of analysis we still didn’t have permission to connect our data to HUSK/LUTS 
questionnaire. Thus, we used the first wave as baseline. The term “new-onset UI” was 
mostly used in clinical studies before. The concept of “new-onset” is not different 
from “incident”, but we used this term with attempt to follow up the cases.  
Our study showed that the new-onset UI in middle-aged women is mainly of stress 
type and of slight severity. We also found that the distribution of new-onset urgency 
and mixed UI are almost the same. Nevertheless, women with new-onset UI almost 
never experienced severe UI directly from start. Distributions of women in all three 
pre-modified subgroups were almost the same. 
In subgroup A, women experienced a transient UI. Our study showed that women in 
this subgroup had a larger proportion of non-classified UI and a smaller proportion of 
moderate UI compare to other subgroups. Women in Subgroup B had experienced an 
on-and-off UI and they had also mostly slight stress UI. But compared to Subgroup 
A, moderate new-onset UI was reported slightly more. In Subgroup B, severity of UI 
showed a small increase in severity in the second time. In subgroup C, UI was 
persistent. However, the type and severity of UI did not change in most cases, 
especially not in women with stress new-onset UI. Compared with other subgroups, it 
seems that women with mixed new-onset UI, had more tendency to get persistent UI.  
Compared with previous studies on natural history of UI, our study had some strong 
features such as: the number of waves, narrow age-spans and the short interval 
durations. Previous studies had one or two follow-ups, a wide age-span, and long 
intervals between checkpoints46,53,56-58,73,119-121. However, in those studies, despite of 
differences in definitions of UI and age distribution, they showed the dynamic nature 
of UI. The results for incidence and remission of UI, from Townsend et al58 and 
Lifford et al121, are in the same range as our results in Paper II. The result for type 
shifts in our study is compatible with two other studies; one46, which reported one-
third of women with stress or mixed UI at baseline had the same type after five years, 
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and another121, which reported a similar results after 2 years. Thom et al73 also 
reported a 31.0% incidence of new-onset UI during approximately 5 years.  
Studies have shown that mixed UI is far more common than expected if pure stress 
and pure urgency UI are assumed to be independent, but the reasons for this finding is 
not known. A recent empirical study 122 discussed three possible explanatory models 
for this finding. First, the “Risk Factor model” suggests a common set of risk factors 
(including obesity, parity, prolapse) exists for both stress and urgency UI. Second, the 
“Liability model”, which assume that if a woman has already one type of UI (stress or 
urgency), she has higher risk to get the other type and develop mixed UI; or if the 
likelihood of remission of symptoms is lower for mixed UI than for either stress or 
urgency UI. Third, the “Severity model” is supported if UI symptoms are more 
persistent with mixed UI than with pure stress or urgency UI, specifically, the 
severity model would dictate that on any given day, women with mixed UI are more 
likely to exhibit UI symptoms. The authors explored the extent to which evidence 
supported each model. They found little support to indicate that the excess prevalence 
of mixed UI was explained by common risk factors. In contrast, they found evidence 
to indicate that onset of one UI subtype increased risk of onset of the other subtype. 
Although they found the Severity model attractive, they had little epidemiological 
evidence to support it.  
Our study did not include risk factor data and hence we could not evaluate the Risk 
Factor model. But regarding the Liability model, our data showed no support, 
because we found a high transition from mixed UI to stress or urgency UI, which 
indicated that mixed UI is also very dynamic with high remission rate to its two 
components. This finding was against previous studies that claimed the likelihood of 
remission of symptoms is lower for mixed UI than for either stress or urgency 
UI27,46,57,58,74. Our data is more in favour of the Severity model, because we included 
women with new-onset UI through follow-ups and not by invitation, thus we 
removed the factor of “personal tendency for participation in a survey”. We found 
that the proportion of mixed UI is less than 13.0% at each checkpoint, while previous 
cross-sectional studies have found a proportion between 30-45% for the same age-
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group9,123, even in a Norwegian study that used the same questionnaire6. The high 
prevalence of mixed UI in cross-sectional studies may possibly be explained by 
response bias. Previous studies showed that women with mixed UI have more severe 
symptoms compared to pure stress or urgency UI9,123,124. Therefore, based on the 
Severity model, we suggest that women with mixed UI, due to more severe 
symptoms, exhibit their problem more than women with single stress or urgency UI. 
We also suggest adding a new dimension to this model, namely response bias.  
6.3 Recommendation for further research 
Epidemiologic survey of UI, as a symptom, is different from clinical study of UI. 
This feature is different from many other studies that use self-reports of diagnosed 
disease states. It is recommended that more sustained research on measurement of UI 
should be performed including, its types and severity to move the research ahead. 
More longitudinal study designs are needed to estimate incidence of UI and describe 
the course of the condition and its different forms and to investigate its risk factors 
and possible protective factors.  Per 2014, two more completed waves of the Cohort 
are available for analyses. Data presented in this dissertation may therefore be 
expanded in future. 
There is still room for improvement of knowledge related to incidence, remission and 
natural history of UI in middle-aged women. It is recommended that age-specific 
epidemiological data should be encouraged, and tailored to the different phases of 
menopause and other risk factors in perimenopausal women. Development of UI 
must be studied in a way that links population-based methods to clinical assessment 
of UI. In middle-aged women, such a design is necessary because the effect of natural 
physiological and hormonal changes may become clear only during longitudinal 
studies with multiple checkpoints and short intervals.  
In order to combine data, studies should be done only with recommended and 
validated questionnaires. Control for confounders, stratification, and multivariate 
techniques should be increasingly used because of the need for more advanced 
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epidemiological analyses of risk factors and comorbidity. There should be more 
emphasis on the associations between UI and specific diseases. Genetic components 
should be investigated. Primary prevention is the main goal on the management of 
human disease. An important strategy would thus be to identify the individuals at 
risk, and then take measures to reduce the risk among those individuals or in certain 
risk groups. Based on current knowledge there are no well-documented efforts that 
can be done in order to avoid the occurrence of UI in large populations. Primary 
prevention studies should be encouraged, but the epidemiological basis for choosing 
appropriate intervention is weak. 
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